{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T02:58:40Z","timestamp":1792292320177,"version":"4.4.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2007,4,27]],"date-time":"2007-04-27T00:00:00Z","timestamp":1177632000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Infect Dis Rep"],"published-print":{"date-parts":[[2007,5]]},"DOI":"10.1007\/s11908-007-0036-x","type":"journal-article","created":{"date-parts":[[2007,4,26]],"date-time":"2007-04-26T07:51:06Z","timestamp":1177573866000},"page":"228-232","source":"Crossref","is-referenced-by-count":22,"title":["Pulmonary infections in the HIV-infected patient in the era of highly active antiretroviral therapy: An update"],"prefix":"10.1007","volume":"9","author":[{"given":"Deepa G.","family":"Lazarous","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne E.","family":"O\u2019Donnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,4,27]]},"reference":[{"key":"36_CR1","first-page":"305","volume":"30","author":"Centers for Disease Control","year":"1981","unstructured":"Centers for Disease Control: Pneumocystis pneumonia: Los Angeles. MMWR 1981, 30:305\u2013308.","journal-title":"MMWR"},{"key":"36_CR2","volume-title":"2004 Report on the Global AIDS Epidemic: 4th global report","author":"UNAIDS","year":"2004","unstructured":"UNAIDS: 2004 Report on the Global AIDS Epidemic: 4th global report. Geneva, Switzerland: UNAIDS; 2004."},{"key":"36_CR3","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJM199803263381301","volume":"338","author":"F.J. Pallela Jr","year":"1998","unstructured":"Pallela FJ Jr, Delaney KM, Moorman AC, et al.: Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med 1998, 338:853\u2013860.","journal-title":"N Engl J Med"},{"key":"36_CR4","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1056\/NEJMoa011157","volume":"345","author":"S.L. Gortmaker","year":"2001","unstructured":"Gortmaker SL, Hughes M, Cervia J, et al.: Effect of combination therapy including protease inhibitors on mortality among children and adolescents infected with HIV-1. N Engl J Med 2001, 345:1522\u20131528.","journal-title":"N Engl J Med"},{"key":"36_CR5","first-page":"331","volume-title":"Cytokines in Pulmonary Disease: Infection and Inflammation","author":"T.L. Benfield","year":"2000","unstructured":"Benfield TL, Lundgren JD, Masur H: HIV-1, cytokines, and the lung. In Cytokines in Pulmonary Disease: Infection and Inflammation. Edited by Nelson S, Martin TR. New York: Marcel Dekker; 2000:331\u2013364."},{"key":"36_CR6","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1165\/ajrcmb.20.5.3547","volume":"20","author":"I.W. Park","year":"1999","unstructured":"Park IW, Koziel H, Hatch W, et al.: CD4 receptor-dependent entry of human immunodeficiency virus type-1 env-pseudo-types into CCR5-, CCR3-, and CXCR4-expressing human alveolar macrophages is preferentially mediated by the CCR5 coreceptor. Am J Respir Cell Mol Biol 1999, 20:864\u2013871.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"36_CR7","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1164\/ajrccm.164.11.2102047","volume":"164","author":"J. Beck","year":"2001","unstructured":"Beck J, Rosen M, Peavy H: Pulmonary Complications of HIV Infection. Report of the Fourth NHLBI Workshop. Am J Respir Crit Care Med 2001, 164:2120\u20132126.","journal-title":"Am J Respir Crit Care Med"},{"key":"36_CR8","doi-asserted-by":"crossref","first-page":"6680","DOI":"10.1128\/JVI.73.8.6680-6690.1999","volume":"73","author":"A. Singh","year":"1999","unstructured":"Singh A, Besson G, Mobasher A, Collman RG: Patterns of chemokine receptor fusion cofactor utilization by human immunodeficiency virus type 1 variant from the lungs and blood. J Virol 1999, 73:6680\u20136690.","journal-title":"J Virol"},{"key":"36_CR9","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1378\/chest.120.6.1888","volume":"120","author":"A.J. Wolff","year":"2001","unstructured":"Wolff AJ, O\u2019Donnell A: Pulmonary manifestations of HIV infection in the era of highly active anti retroviral therapy. Chest 2001, 120:1888\u20131893.","journal-title":"Chest"},{"key":"36_CR10","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1097\/00126334-200204010-00010","volume":"29","author":"G. Dore","year":"2002","unstructured":"Dore G, Li Y, McDonald A, et al.: Impact of highly active antiretroviral therapy on individual AIDS-defining illness incidence and survival in Australia. J Acquir Immune Defic Syndr 2002, 29:388\u2013395. [Erratum in J Acquir Immune Defic Syndr 2002, 30:368.]","journal-title":"J Acquir Immune Defic Syndr"},{"key":"36_CR11","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1089\/108729103322108139","volume":"17","author":"J. Pulverenti","year":"2003","unstructured":"Pulverenti J, Herrera P, Venkataraman P, Ahmad N: Pneumocystic carinii penumonia in HIV-infected patients in the HAART era. AIDS Patient Care STDs 2003, 17:261\u2013265.","journal-title":"AIDS Patient Care STDs"},{"key":"36_CR12","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/S0140-6736(99)03320-6","volume":"354","author":"J. Helweg-Larsen","year":"1999","unstructured":"Helweg-Larsen J, Benfield TL, Eugen-Olsen J, et al.: Effects of mutations in Pneumocystis carinii dihydropteroate synthase gene on outcome of AIDS-associated P. carinii pneumonia. Lancet 1999, 354:1347\u20131351.","journal-title":"Lancet"},{"key":"36_CR13","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1056\/NEJM199904293401701","volume":"340","author":"H. Furrer","year":"1999","unstructured":"Furrer H, Egger M, Opravil M, et al.: Discontinuation of primary prophylaxis against Pneumocytis carinii pneumonia in HIV-1-infected adults treated with combination antiretroviral therapy. Swiss HIV Cohort Study. N Engl J Med 1999, 340:1301\u20131306.","journal-title":"N Engl J Med"},{"key":"36_CR14","doi-asserted-by":"crossref","first-page":"873","DOI":"10.7326\/0003-4819-131-11-199912070-00022","volume":"131","author":"H. Masur","year":"1999","unstructured":"Masur H, Kaplan JE, Holmes KK, et al.: 1999 USPHS\/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus. Ann Intern Med 1999, 131:873\u2013908.","journal-title":"Ann Intern Med"},{"key":"36_CR15","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1056\/NEJM200101183440301","volume":"344","author":"J.C. Lopez Bernaldo de Quiros","year":"2001","unstructured":"Lopez Bernaldo de Quiros JC, Miro JM, Pena JM, et al.: A randomized trial of the discontinuation of primary and secondary prophylaxis against Pneumocystis carinii pneumonia after highly active antiretroviral therapy in patients with HIV infection. Grupo de Estudio del SIDA 04\/98. N Engl J Med 2001, 344:159\u2013167.","journal-title":"N Engl J Med"},{"key":"36_CR16","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1056\/NEJM200101183440302","volume":"344","author":"B. Ledergerber","year":"2001","unstructured":"Ledergerber B, Mocroft A, Reiss P, et al.: Discontinuation of secondary prophylaxis against Pneumocystis carinii pneumonia in patients with HIV infection who have a response to antiretroviral therapy. N Engl J Med 2001, 344:168\u2013174.","journal-title":"N Engl J Med"},{"key":"36_CR17","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/00002030-200301030-00010","volume":"17","author":"A. Morris","year":"2003","unstructured":"Morris A, Wachter R, Luce J, et al.: Improved survival with highly active antiretroviral therapy in HIV-infected patients with severe Pneumocystis carinii pneumonia. AIDS 2003, 17:73\u201380.","journal-title":"AIDS"},{"key":"36_CR18","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1136\/thx.2005.055905","volume":"61","author":"R.F. Miller","year":"2006","unstructured":"Miller RF, Allen E, Copas A, et al.: Improved survival for HIV infected patients with severe Pneumocystis jirovecii pneumonia is independent of highly active antiretroviral therapy. Thorax 2006, 61:716\u2013721.","journal-title":"Thorax"},{"key":"36_CR19","first-page":"203","volume":"11","author":"R.J. Boyton","year":"2005","unstructured":"Boyton RJ: Infectious lung complications in patients with HIV\/AIDS. Curr Opin Pulm Med 2005, 11:203\u2013207.","journal-title":"Curr Opin Pulm Med"},{"key":"36_CR20","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1056\/NEJM199509283331305","volume":"333","author":"R.E. Hirschtick","year":"1995","unstructured":"Hirschtick RE, Glassroth J, Jordan MC, et al.: Bacterial pneumonia in persons infected with the human immunodeficiency virus. Pulmonary Complications of HIV Infection Study Group. N Engl J Med 1995, 333:845\u2013851.","journal-title":"N Engl J Med"},{"key":"36_CR21","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S1473-3099(04)01060-6","volume":"4","author":"D. Feikin","year":"2004","unstructured":"Feikin D, Feldman C, Schuchat A, Janoff E: Global strategies to prevent bacterial pneumonia in adults with HIV disease. Lancet Infect Dis 2004, 4:445\u2013455.","journal-title":"Lancet Infect Dis"},{"key":"36_CR22","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1164\/ajrccm.162.1.9904101","volume":"162","author":"J.H. Sullivan","year":"2000","unstructured":"Sullivan JH, Moore RD, Keruly JC, Chaisson RE: Effect of antiretroviral therapy on the incidence of bacterial pneumonia in patients with advanced HIV infection. Am J Respir Crit Care Med 2000, 162:64\u201367.","journal-title":"Am J Respir Crit Care Med"},{"key":"36_CR23","doi-asserted-by":"crossref","first-page":"182","DOI":"10.7326\/0003-4819-132-3-200002010-00003","volume":"132","author":"J.P. Nuorti","year":"2000","unstructured":"Nuorti JP, Butler JC, Gelling L, et al.: Epidemiologic relationship between HIV and invasive pneumococcal disease in San Francisco County California. Ann Intern Med 2000, 132:182\u2013190.","journal-title":"Ann Intern Med"},{"key":"36_CR24","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1086\/319218","volume":"32","author":"M.S. Dworkin","year":"2001","unstructured":"Dworkin MS, Ward JW, Hanson DL, et al.: Pneumococcal disease among human immunodeficiency virus-infected persons: incidence, risk factors, and impact of vaccination. Clin Infect Dis 2001, 32:794\u2013800.","journal-title":"Clin Infect Dis"},{"key":"36_CR25","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/00042560-199805010-00006","volume":"18","author":"M. Tumbarello","year":"1998","unstructured":"Tumbarello M, Tacconelli E, de Gaetano K, et al.: Bacterial pneumonia in HIV-infected patients: analysis of risk factors and prognostic indicators. J Acquir Immune Defic Syndr Hum Retrovirol 1998, 18:39\u201345.","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"36_CR26","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1056\/NEJM199106063242307","volume":"324","author":"P.F. Barnes","year":"1991","unstructured":"Barnes PF, Bloch AB, Davidson PT, Snider DE Jr: Tuberculosis in patients with human immunodeficiency virus infection. N Engl J Med 1991, 324:1644\u20131650.","journal-title":"N Engl J Med"},{"key":"36_CR27","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1056\/NEJM199201233260404","volume":"326","author":"C.L. Daley","year":"1992","unstructured":"Daley CL, Small PM, Schecter GF, et al.: An outbreak of tuberculosis with accelerated progression among persons infected with the human immunodeficiency virus. An analysis using restriction-fragment-length polymorphisms. N Engl J Med 1992, 326:231\u2013235.","journal-title":"N Engl J Med"},{"key":"36_CR28","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1086\/338641","volume":"34","author":"G. Santoro-Lopes","year":"2002","unstructured":"Santoro-Lopes G, de Pinho AM, Harrison LH, et al.: Reduced risk for tuberculosis among Brazilian patients with advanced human immunodeficiency virus infection treated with highly active antiretroviral therapy. Clin Infect Dis 2002, 34:543\u2013546.","journal-title":"Clin Infect Dis"},{"key":"36_CR29","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1086\/498315","volume":"41","author":"E. Girardi","year":"2005","unstructured":"Girardi E, Sabin CA, d\u2019Arminio Monforte A, et al.: Incidence of Tuberculosis among HIV-infected patients receiving highly active antiretroviral therapy in Europe and North America. Clin Infect Dis 2005, 41:1772\u20131782.","journal-title":"Clin Infect Dis"},{"key":"36_CR30","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1097\/01.aids.0000194808.20035.c1","volume":"19","author":"S.D. Lawn","year":"2005","unstructured":"Lawn SD, Badri M, Wood R: Tuberculosis among HIV-infected patients receiving HAART: long term incidence and risk factors in a South African cohort. AIDS 2005, 19:2109\u20132116.","journal-title":"AIDS"},{"key":"36_CR31","first-page":"1","volume":"47","author":"Centers for Disease ControlPrevention","year":"1998","unstructured":"Centers for Disease Control and Prevention: Prevention and treatment of tuberculosis among patients infected with human immunodeficiency virus: principles of therapy and revised recommendations. Morbid Mortal Weekly Rep 1998, 47:1\u201358.","journal-title":"Morbid Mortal Weekly Rep"},{"key":"36_CR32","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1093\/jac\/dkh438","volume":"54","author":"C. Hung","year":"2004","unstructured":"Hung C, Chang S: Impact of highly active antiretroviral therapy on incidence and management of human immunodeficiency virus-related opportunistic infections. J Antimicrob Chemother 2004, 54:849\u2013853.","journal-title":"J Antimicrob Chemother"},{"key":"36_CR33","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/00002030-200201040-00010","volume":"16","author":"G.L. Dean","year":"2002","unstructured":"Dean GL, Edwards SG, Ives NJ, et al.: Treatment of tuberculosis in HIV-infected persons in the era of highly active antiretroviral therapy. AIDS 2002, 16:75\u201383.","journal-title":"AIDS"},{"issue":"RR08","key":"36_CR34","first-page":"1","volume":"51","author":"Guidelines for Preventing Opportunistic Infections Among HIV-Infected Persons\u20142002.","year":"2002","unstructured":"Guidelines for Preventing Opportunistic Infections Among HIV-Infected Persons\u20142002. Recommendations of the U.S. Public Health Service and the Infectious Diseases Society of America. MMWR 2002, 51(RR08):1\u201346.","journal-title":"MMWR"},{"key":"36_CR35","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/00002030-199703110-00009","volume":"11","author":"N. Salomon","year":"1997","unstructured":"Salomon N, Gomez T, Permian DC, et al.: Clinical features and outcomes of HIV-related cytomegalovirus pneumonia AIDS 1997, 11:319\u2013324.","journal-title":"AIDS"},{"key":"36_CR36","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1378\/chest.107.3.735","volume":"107","author":"C.E. Hayner","year":"1995","unstructured":"Hayner CE, Baughman RP, Linnemann CC Jr, Dohn MN: The relationship between cytomegalovirus retrieved by bronchoalveolar lavage and mortality in patients with HIV. Chest 1995, 107:735\u2013740.","journal-title":"Chest"},{"key":"36_CR37","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1097\/00002030-199004000-00005","volume":"4","author":"M. Bower","year":"1990","unstructured":"Bower M, Barton SE, Nelson MR, et al.: The significance of the detection of cytomegalovirus in the bronchoalveolar lavage fluid in AIDS patients with pneumonia. AIDS 1990, 4:317\u2013320.","journal-title":"AIDS"},{"key":"36_CR38","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1086\/313809","volume":"30","author":"V.C. Cheng","year":"2000","unstructured":"Cheng VC, Yuan KY, Chan WM, et al.: Immunorestitution disease involving the innate and adaptive response. Clin Infect Dis 2000, 30:882\u2013892.","journal-title":"Clin Infect Dis"},{"key":"36_CR39","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1086\/383034","volume":"38","author":"H.H. Hirsch","year":"2004","unstructured":"Hirsch HH, Kaufmann G, Sendi P, Battegay M: Immune reconstitution in HIV infected patients. Clin Infect Dis 2004, 38:1159\u20131166.","journal-title":"Clin Infect Dis"},{"key":"36_CR40","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1086\/323898","volume":"34","author":"E.L. Cooney","year":"2002","unstructured":"Cooney EL: Clinical indicators of immune restoration following highly active antiretroviral therapy. Clint Infect Dis 2002, 34:224\u2013233.","journal-title":"Clint Infect Dis"},{"key":"36_CR41","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1046\/j.1468-1293.2000.00012.x","volume":"1","author":"M.A. French","year":"2000","unstructured":"French MA, Lenz N, John M, et al.: Immune restoration disease after the treatment of immunodeficient HIV infected patients with highly active antiretroviral therapy. HIV Med 2000, 1:107\u2013115.","journal-title":"HIV Med"},{"key":"36_CR42","first-page":"167","volume":"9","author":"R.E. Davaro","year":"1999","unstructured":"Davaro RE, Himlan PH: Immune restoration disorders following HAART. AIDS Read 1999, 9:167\u2013169.","journal-title":"AIDS Read"},{"key":"36_CR43","first-page":"1","volume-title":"HIV\/AIDS Surveillance Report, 2003 (Vol. 15)","author":"Centers for Disease ControlPrevention","year":"2004","unstructured":"Centers for Disease Control and Prevention: HIV\/AIDS Surveillance Report, 2003 (Vol. 15). Atlanta: US Department of Health and Human Services, Centers for Disease Control and Prevention; 2004:1\u201346."},{"key":"36_CR44","doi-asserted-by":"crossref","first-page":"S245","DOI":"10.1097\/01.CCM.0000232491.15369.AB","volume":"34","author":"M.J. Rosen","year":"2006","unstructured":"Rosen MJ, Narasimhan M: Critical care of immuno-compromised patients: Human immunodeficiency virus. Cirt Care Med 2006, 34:S245\u2013S250.","journal-title":"Cirt Care Med"},{"key":"36_CR45","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1056\/NEJMra050836","volume":"355","author":"L. Huang","year":"2006","unstructured":"Huang L, Quartin A, Jones D, Havlir D: Intensive care of patients with HIV infection. N Engl J Med 2006, 355:173\u2013181.","journal-title":"N Engl J Med"}],"container-title":["Current Infectious Disease Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11908-007-0036-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11908-007-0036-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11908-007-0036-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,21]],"date-time":"2020-04-21T14:50:50Z","timestamp":1587480650000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11908-007-0036-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,4,27]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,5]]}},"alternative-id":["36"],"URL":"https:\/\/doi.org\/10.1007\/s11908-007-0036-x","relation":{},"ISSN":["1523-3847","1534-3146"],"issn-type":[{"value":"1523-3847","type":"print"},{"value":"1534-3146","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,4,27]]}}}